247 filings
8-K
MTEM
Molecular Templates Inc
12 Apr 24
Cost Associated with Exit or Disposal Activities
4:22pm
8-K
MTEM
Molecular Templates Inc
29 Mar 24
Molecular Templates, Inc. Reports Fourth Quarter 2023 Financial Results and Business Update
8:45am
8-K
MTEM
Molecular Templates Inc
28 Mar 24
Molecular Templates Announces $9.5 Million Private Placement Offering and Agreement to Amend Second Tranche of July 2023 Purchase Agreement
8:22am
8-K
MTEM
Molecular Templates Inc
15 Mar 24
Termination of a Material Definitive Agreement
4:08pm
8-K
MTEM
Molecular Templates Inc
17 Jan 24
Departure of Directors or Certain Officers
4:04pm
8-K
u2wxs
13 Nov 23
Molecular Templates, Inc. Reports Third Quarter 2023 Financial Results and Business Update
4:13pm
8-K
btt tzqqvh
27 Oct 23
Submission of Matters to a Vote of Security Holders
4:12pm
8-K
y5yi 3q756nn7fow
28 Sep 23
Molecular Templates Announces the Appointment of Dr. Maurizio Voi to the Role of Chief Medical Officer
5:01pm
8-K
fxslppvb3n5xy 5r0h0
31 Aug 23
Other Events
4:11pm
8-K
trlevk47bpa3r3
11 Aug 23
Molecular Templates Announces 1-for-15 Reverse Stock Split
4:12pm
8-K
g30qk 1vu1
10 Aug 23
Molecular Templates, Inc. Reports Second Quarter 2023 Financial Results and Business Update
8:09am
8-K
2dwlqfn
2 Aug 23
Molecular Templates Announces Executive Leadership Changes
4:16pm
8-K
5utcui9zcx qnfc5x
13 Jul 23
Molecular Templates Announces Up to $40 Million Private Placement Offering
12:48pm
8-K
5mg o5mxfzy
20 Jun 23
Molecular Templates Announces Debt Payoff and Restructuring
7:00am
8-K
l1k9zk4ca8 po
16 Jun 23
Molecular Templates Announces Debt Payoff and Restructuring
8:56pm
8-K
qf4o4og wpp1m
1 Jun 23
Other Events
7:59am
8-K
i6daq ypu68ag
26 May 23
Molecular Templates to Present on Phase I Dose Escalation Study of MT-6402 at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting
5:16pm
8-K
lhl91vawe
15 May 23
Molecular Templates, Inc. Reports First Quarter 2023 Financial Results and Business Update
4:49pm
8-K
5t81m9t
7 Apr 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:18pm
8-K
hb43x0tdmkjt84
30 Mar 23
Molecular Templates, Inc. Reports Fourth Quarter 2022 Financial Results and Business Update
6:19pm